Company Analysis

Intercure Ltd. (INCR)

Nasdaq: INCR · Pharmaceutical Preparations · Herzliya, IL · filing with the SEC since 2021
Grade4.7
◀ Past 6.6● Present 5.3▶ Future 1.8
2 est.

Who runs Intercure Ltd.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rabinovich Alexander
Chief Executive Officer. First filing Apr 2026, latest Apr 20, 2026, 0 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Cohen AmosChief Financial OfficerApr 2026Aug 24, 2026none
Rabinovich AlexanderChief Executive OfficerApr 2026Apr 20, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Granot Alon ShmueldirectorApr 2026Apr 20, 2026none
Michelson Lennie GrinbaumdirectorApr 2026Apr 20, 2026none
Hirschfeld GideondirectorApr 2026Apr 16, 2026none
Salton DaviddirectorApr 2026Apr 16, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton INCR · research, not advice